The Brain Trial: a Randomised, Placebo Controlled Trial of a Bradykinin B2 Receptor Antagonist (Anatibant) in Patients with Traumatic Brain Injury
AuthID
P-003-DNQ
P-003-DNQ
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service